Back to Search
Start Over
P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.
- Source :
- HemaSphere, Vol 7, p e760520f (2023)
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2e058edddd5c462baa7ae7dd125ceb33
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/01.HS9.0000972932.76052.0f